OFS: Don’t miss today’s game-changing IPO opportunity!

Company Overview

OFS Capital Corporation (NASDAQ: OFS) is a publicly traded business development company (BDC) that provides capital to North American middle-market companies. The firm’s portfolio spans senior secured loans (first-lien and second-lien), subordinated/unitranche loans, and minority equity stakes, aiming to generate both current income and capital appreciation for shareholders (^[1]). OFS is externally managed by OFS Capital Management (part of the Orchard First Source Asset Management group), which handles the investment decisions in exchange for management and incentive fees. Shares of OFS currently trade around $8.70, down over 20% in the past year (^[2]), but sporting an eye-catching dividend yield of roughly 15% (^[1]). This high yield and a deeply discounted stock price (about 0.8× book value, as NAV was $10.91 per share at 6/30/2025 (^[3])) suggest the market anticipates significant risks ahead – but they also hint at opportunity, especially given a unique situation in OFS’s investment portfolio. In particular, an outsized equity holding in a pharmaceutical company has recently driven big NAV swings, and a potential monetization (via sale or IPO) of that asset could be a game-changer for OFS. Below, we dive into OFS’s dividend policy, financial leverage, portfolio composition, valuation, and the key risks and catalysts – including that “IPO opportunity” – that investors should weigh.

Dividend Policy and Coverage

OFS Capital has a history of generous dividends, but the sustainability of its payout is a central question. As a regulated investment company (RIA) and BDC, OFS must distribute most of its taxable income to shareholders. Prior to 2020, OFS consistently paid $0.34 per share quarterly, but the COVID-19 shock forced a sharp cut – the dividend was slashed to $0.17 in Q3 2020 (^[4]). Thereafter, management began rebuilding the payout. Through 2021–2022, OFS increased its dividend every few quarters, reaching $0.25 by Q4 2021 and $0.30 by Q4 2022 (^[5]) (^[5]). In 2023, as economic conditions improved, OFS made two more raises: from $0.30 to $0.33 in Q1 2023, and then to $0.34 by Q4 2023 (^[5]). As of the latest declaration, the quarterly dividend remains $0.34, equating to a $1.36 annualized payout (a 15%+ yield at the current share price) (^[1]).

Dividend Coverage. A crucial issue is whether OFS’s earnings support this dividend. BDCs use Net Investment Income (NII) – essentially, recurring income from investments minus expenses – as the metric for dividend coverage (analogous to a REIT’s FFO). In 2022 and the first half of 2023, rising interest rates on OFS’s largely floating-rate debt portfolio boosted NII and coverage. For example, in Q3 2023 OFS earned $0.40 NII per share, comfortably above the $0.34 payout (^[6]) (^[6]). However, more recently coverage has deteriorated. By Q3 2024, NII had fallen to just $0.27 per share (^[7]), and in Q2 2025 NII was only $0.25 – well short of the $0.34 dividend (^[3]). This means only ~75% of the dividend was covered by current net income in mid-2025, with the remainder effectively coming from fee waivers, realized gains, or a return of capital. Such a shortfall raises obvious sustainability concerns. An independent analysis in 2024 noted that OFS’s NII “remains insufficient to support its high dividend” and warned that the fund may need to reduce the payout barring a turnaround (^[8]). Management has so far maintained the $0.34 quarterly distribution (even declaring it again for Q3 2025) despite the coverage gap (^[3]), perhaps anticipating improved earnings or one-time gains. Investors should monitor upcoming quarters closely – if NII doesn’t rebound, pressure to cut the dividend will intensify. As one analyst predicted, a dividend reduction before 2025 ends is a real possibility if earnings don’t improve (^[8]).

It’s worth noting that BDCs can sometimes utilize realized capital gains or undistributed prior-year income to help fund distributions if NII falls short. OFS did realize some gains in late 2024 (discussed later) which bolstered overall net income (^[9]) (^[9]). Still, relying on non-recurring gains to fund regular dividends is not a long-term strategy. In summary, OFS’s 15% yield is undeniably attractive, but at present it comes with a red flag – the dividend’s coverage by recurring income is weak. Unless portfolio income grows or the payout is right-sized, this high yield may prove unsustainable.

Leverage and Debt Maturities

Like most BDCs, OFS employs leverage to enhance returns, borrowing money at fixed or floating interest to invest in higher-yielding loans. Regulatory rules require a BDC to maintain at least 150% asset coverage of debt (debt-to-equity of 2:1 or less). OFS has operated near this limit at times, reflecting an aggressive use of debt. During the pandemic downturn, for instance, OFS’s asset coverage ratio was 166% as of June 30, 2020 (^[4]) – not far above the minimum 150% threshold. At that date the company had approximately $153 million in unsecured bonds and $134 million in SBA debentures outstanding (^[4]), on a base of $135 million in net assets (^[4]). In other words, debt was about 2× equity at the height of the 2020 crisis, magnifying both gains and losses. Management took steps to de-lever slightly in subsequent years (including issuing some equity through “at-the-market” programs and allowing profits to bolster NAV), but OFS still today has a fairly high leverage ratio around the regulatory limit. Investors get the benefit of an amplified 15% ROE (via leverage) when things go well – but also bear the risk that even a mild portfolio downturn can dent NAV and potentially trip leverage covenants.

Debt Structure & Maturities. OFS’s funding mix includes unsecured notes (tradeable “baby bonds”) as well as secured credit facilities. The company has been proactive in managing its maturities. As of mid-2025, a major focus was addressing a $125 million issue of 4.75% notes due February 2026. In July 2025, OFS raised $69.0 million in fresh capital by issuing new 7.50% notes due July 31, 2028, and used the proceeds (along with other available cash) to redeem the 4.75% 2026 notes ahead of schedule (^[3]) (^[3]). This refinancing pushed out OFS’s nearest debt maturity to 2028, at the cost of a higher interest rate. The company continues to have $55 million of 4.95% notes due October 2028 outstanding as well (^[10]). By replacing lower-coupon 4.75% debt with 7.50% debt, OFS will see a notable rise in interest expense going forward – ~$2.5 million in extra annual interest costs on the portion refinanced, all else equal. This change partially explains the recent drop in NII, as new debt is more expensive while some older investments have been repaid or marked down.

In addition to its bonds, OFS maintains revolving credit facilities for shorter-term funding. It had a senior secured credit line with Banc of California and another credit facility with BNP Paribas. As of mid-2025, OFS had significant unused borrowing capacity – about $86.6 million undrawn under the BNP facility alone (^[3]) – subject to collateral borrowing base requirements. These lines provide liquidity to make new investments or cover short-term needs. The BNP facility was previously set to mature in 2024 (^[4]), but the company likely extended or refinanced it (exact terms weren’t disclosed in the latest press release). Notably, in early 2024 OFS fully repaid its outstanding SBA debentures (government-backed small business investment loans) ahead of their 2025 maturity (^[11]). This repayment and the surrender of its SBIC license freed OFS from SBIC regulatory constraints, but also eliminated some low-cost, long-term funding.

Interest Coverage and Covenants. At the end of the day, what matters is that OFS can comfortably service its debt. In 2023–2024, interest expense ran around $4–5 million per quarter (^[12]), consuming roughly half of total investment income. With the new higher-rate debt, interest costs will rise, putting pressure on net income unless asset yields also increase. Currently, OFS’s NII is barely covering its interest expense (for example, Q4 2023 NII of $4.7M was essentially equal to the $4.7M interest outlay (^[12])). This leaves a thin margin of safety; any reduction in income or increase in borrowing costs could squeeze earnings further. That said, OFS remains in compliance with all debt covenants as of the latest reports, and the proactive refinancing to 2028 has reduced near-term rollover risk. The trade-off is higher leverage cost and, by extension, higher risk to equity holders if performance falters. Investors should watch OFS’s leverage ratio and asset coverage closely each quarter. A significant NAV decline (e.g. from credit losses) could tighten the asset coverage buffer, potentially limiting OFS’s ability to pay distributions or make new investments until corrected. Conversely, successful investment exits or equity raises that boost NAV can improve leverage metrics and ease those concerns.

Portfolio Composition and “IPO” Upside

OFS Capital’s investment portfolio is diverse across industries but has a notable concentration in one particular holding that could potentially be an “IPO opportunity.” First, a broad overview: as of Q3 2023, about 99% of OFS’s loan portfolio consisted of senior secured loans, and roughly 94% of all loans carried floating interest rates (^[6]). This means OFS benefits when benchmark rates rise (borrowers pay higher interest), but it also means borrowers’ health is sensitive to rate hikes. The portfolio is split between debt investments (~81% of total, at fair value) and equity/structured finance investments (~19%) (^[12]). The debt portion yields around 13–14% on average, reflecting the middle-market, often sub-investment-grade nature of borrowers (^[6]). The smaller equity portion is where things get especially interesting – and risky.

Pfanstiehl Holdings – a Concentrated Bet: OFS’s single largest investment is its common equity stake in Pfanstiehl Holdings, Inc., a private manufacturer of specialty pharmaceutical ingredients. As of June 30, 2024, OFS owned 400 Class A shares of Pfanstiehl, carried at a fair value of $70.8 million (^[13]) (^[13]). To put that in perspective, Pfanstiehl comprised 17.8% of OFS’s total investment portfolio (at value) and a striking 45.9% of OFS’s net assets at that date (^[13]). In other words, nearly half of the book value of OFS is tied up in this one equity investment. This extreme concentration is a double-edged sword. On one hand, it presents a game-changing upside opportunity: if Pfanstiehl is sold or taken public at a strong valuation, OFS could realize a windfall gain and a cash infusion. On the other hand, any setback at Pfanstiehl could severely dent OFS’s NAV (as has happened before during write-downs).

So far, Pfanstiehl’s valuation has been volatile but net-positive for OFS. In late 2021, OFS marked up the position by $10.1 million in one quarter (^[14]), contributing significantly to a NAV rise that year. More dramatically, in Q4 2024, OFS recorded a $15.6 million unrealized appreciation on its Pfanstiehl stake (^[9]), helping boost NAV per share from $11.29 to $12.85 in that quarter (^[9]) (^[9]). Management hasn’t publicly detailed why Pfanstiehl’s value jumped – but such a gain often implies a catalyst like improved financial performance or an impending deal. It’s conceivable that Pfanstiehl attracted a strategic suitor or was preparing for an IPO, prompting OFS’s valuation committee to mark it higher. Indeed, the “Don’t miss today’s IPO opportunity” angle likely refers to the potential monetization of Pfanstiehl. Should that company successfully IPO or be acquired, OFS might finally realize the large paper gains it’s been carrying (perhaps even above the current $70+ million mark, if the market assigns a premium). The proceeds could be redeployed or paid out as a special dividend to OFS shareholders.

However, investors must temper their optimism with caution. Pfanstiehl’s value hasn’t risen in a straight line – it’s also seen downdrafts. In the first half of 2024, OFS actually wrote down the Pfanstiehl equity by a combined $10.6 million (a $7.9M unrealized depreciation in Q1 and another $2.7M in Q2) amid broader market volatility (^[13]) (^[13]). These declines suggest that the earlier marks were partially reversed, before the big rebound in Q4 2024. Such swings underscore how subjective and uncertain private equity valuations can be. Until Pfanstiehl is converted to cash, its value on OFS’s books is an estimate. Notably, Pfanstiehl was originally acquired in 2013 by a private equity firm (MedOpportunity Partners) – now, over a decade later, an exit could be on the horizon. Any news of a sale or IPO filing for Pfanstiehl will be critical for OFS, and likely the “game-changer” that the report title implies. This single investment could produce a massive positive catalyst if things go right, or a significant hit to NAV if things go wrong (for example, if no liquidity event materializes and business conditions deteriorate).

Other Portfolio Holdings: Outside of Pfanstiehl, the rest of OFS’s portfolio is more granular. The debt investments are spread across roughly 40+ companies in industries like business services, healthcare, manufacturing, and technology. One of the larger debt positions is All Star Auto Lights (aftermarket auto parts distribution), a first-lien loan around $27 million (^[13]) (^[13]). OFS also invests in structured finance securities (CLO equity and subordinated notes), which made up about $79 million of the portfolio at the end of 2023 (^[12]). These CLO investments can add extra yield but also volatility (they contributed some unrealized losses in 2023 when credit spreads widened (^[12]) (^[12])). Overall, as of Q2 2025, the portfolio’s weighted average income yield was about 13.6% on performing investments (^[3]) – healthy, but we must net out OFS’s interest costs (~5–6%) and fees to see why NII is under pressure.

Valuation Metrics: Given its portfolio and challenges, OFS’s stock trades at a sizeable discount to NAV. With the stock around $8.70 and latest NAV about $10.91, the price-to-book is roughly 0.8×. This 20% discount reflects investors’ apprehension about asset quality and the dividend. Many higher-quality BDCs trade near or above NAV, so OFS’s discount hints at perceived weakness. Indeed, in late 2024 OFS was trading at an even larger ~30% discount to NAV (^[8])before the Q4 rally in NAV shrank the gap. On an earnings basis, OFS’s valuation is also low – it’s roughly 7× annualized NII (using ~$1.00 NII per share run-rate), compared to 8–10× for some peers. The high dividend yield (15%) is another way of saying the market is pricing in either a dividend cut or deterioration in asset value. If OFS can navigate its challenges and maintain the payout, an investor buying at 0.8× NAV is locking in an outsized yield and could see upside if the discount narrows. Conversely, if NAV falls further or the dividend is cut, the stock could continue to languish.

In summary, OFS appears undervalued on paper, but for justifiable reasons. The bull case is that the market underestimates the value of Pfanstiehl and the resilience of OFS’s income – in which case a successful “IPO event” or improved earnings could lead to a higher NAV and a re-rating of the stock upward. The bear case is that the dividend is not fully earned, asset quality issues (including any hiccup at Pfanstiehl or other loans) could erode NAV, and external management alignment issues persist – thus the discount may be warranted.

Key Risks and Red Flags

Despite its tantalizing yield and potential catalysts, OFS comes with significant risks and red flags that investors must consider:

– Dividend Sustainability: As discussed, the dividend payout exceeds OFS’s recurring income. Paying out more than it earns will erode NAV over time if not corrected. Unless net investment income rebounds (through higher asset yields or portfolio growth) or the dividend is cut, OFS is effectively funding part of its dividend via portfolio run-down or one-time gains. A maintained but uncovered dividend can only last so long. The risk of a dividend cut is elevated – and a cut could hurt the stock price in the short term. On the flip side, management may resist cutting if they expect a big gain (e.g., from Pfanstiehl) to bridge the gap. This is an uncertainty for investors: will OFS cut the dividend to a sustainable level, or attempt to “grow into it”? The answer will materially affect shareholder returns.

– Credit and Portfolio Quality: OFS’s portfolio has exposure to economically sensitive sectors (manufacturing, industrials, etc.), and some investments are underperforming. As of Q2 2025, OFS had non-accrual loans (debt on which the borrower isn’t paying interest) with a fair value of $15.2 million, which is 4.0% of the portfolio by value (^[3]). This non-accrual ratio is somewhat high – higher than many peer BDCs that are under 2-3%. Elevated non-accruals indicate credit issues; while OFS noted no new loans were placed on non-accrual in recent quarters (^[3]), the existing non-performing assets are still being worked out (likely at a loss). For instance, a borrower SSJA Bariatric Management was added to non-accrual in early 2024, contributing to realized losses and writedowns (^[13]). Furthermore, a contributor has pointed out that OFS has above-average exposure to manufacturing and even tariff-sensitive businesses, which could face pressure in a trade war or economic slowdown (^[8]). Any recession or unexpected industry headwinds could lead to more borrowers failing to pay, which would hit OFS’s income and NAV.

– Concentration Risk (Pfanstiehl): While the Pfanstiehl stake offers upside, it is also a huge concentration risk. Nearly half of OFS’s net asset value depends on one company’s fortunes (^[13]). This is far from a diversified approach. If Pfanstiehl were to lose a major customer, face regulatory issues, or if a hoped-for liquidity event fell through, the markdown to OFS’s holdings could be severe. A 45% hit to NAV (in the extreme case that Pfanstiehl’s value went to zero) is unlikely but illustrates the magnitude of risk tied to this single name. Even a more modest change – say a 20% swing in Pfanstiehl’s value – would move OFS’s NAV by about 9%. Essentially, OFS’s fate is unusually entwined with one investment. Investors should watch for any news on Pfanstiehl’s performance or sale process. The lack of control is also a factor: OFS is presumably a minority equity holder and not in the driver’s seat on if/when to exit that position.

– External Management and Fees: OFS is externally managed by an advisor (OFS Capital Management) whose incentives may not perfectly align with common shareholders. The advisor earns a base management fee of 1.75% of assets and an incentive fee of 20% of net investment income (above a hurdle), plus 20% of realized capital gains. One concern is that the base fee is asset-based, not performance-based, which can motivate asset growth even if not value-accretive. Also, the incentive fee structure can lead to situations where the advisor earns fees on paper profits. In Q4 2021, for example, OFS had to accrue a “capital gains” incentive fee due to large unrealized appreciation (primarily on Pfanstiehl), even though that gain wasn’t realized in cash (^[14]). (The capital gains fee wasn’t payable immediately under the contract, but it shows up in expenses under GAAP.) Such fee dynamics can create conflicts of interest – e.g. the advisor might be less inclined to sell an asset like Pfanstiehl early, since unrealized gains bolster fee calculations. Moreover, external management comes with governance concerns: insiders of OFS’s advisor (and its parent OFSAM) own a chunk of OFS’s equity and debt, potentially leading to related-party dealings. While OFS’s board ostensibly oversees the advisor, stockholders ultimately depend on the advisor’s good faith. Any shareholder considering OFS should be comfortable with the track record and integrity of management. The presence of Orchard First Source’s leadership (notably Chairman Richard Ressler, who is involved in OFS’s investment committees (^[10])) suggests experienced hands at the helm, but also ties to other investment vehicles that could compete for deals. In short, the typical external BDC risks – fee drag, conflicts, less transparency – apply to OFS.

– Interest Rate and Market Risk: As a leveraged lender, OFS faces interest rate risk in multiple ways. In 2022–2023, rising rates benefited OFS’s income (because most loans are floating rate), but by late 2023 the effect was moderating and borrower stress was increasing. If rates rise further from here, some OFS portfolio companies might struggle with higher interest burdens, leading to more defaults (and OFS’s own interest expense on its floating debt would also increase). Conversely, if interest rates fall significantly (as the market expects over the next couple years), OFS’s loan income would decline (many loans would see rates reset down), while the company is locked into paying higher fixed rates on its newly issued 7.50% notes through 2028. In fact, OFS noted that the Fed’s 50 bps rate cuts in late 2024 directly caused a drop in its portfolio yield and NII in Q1 2025 (^[15]). So a falling-rate environment could squeeze OFS’s net interest margin unless they can substantially grow the portfolio or reduce borrowing costs. Additionally, broader market volatility (widening credit spreads, lower loan market liquidity) can hit OFS’s marks and deal flow. BDC stocks themselves tend to trade with risk sentiment – and OFS, being a small-cap (<$150M market cap) with low trading volume, could see outsized price swings. The stock’s 5-year beta is around 1.8, indicating high volatility (^[1]). This amplifies both the upside and downside for investors.

– Limited Size and Liquidity: OFS is one of the smaller BDCs on the market. Its modest scale can lead to higher expense ratios (overhead is spread across a smaller asset base) and potentially less bargaining power with borrowers or lenders. Smaller market cap also means the stock can be influenced by retail investor sentiment or forced selling (for example, if a dividend cut were to happen, income-focused funds might dump shares quickly). Liquidity risk isn’t just in the stock; it’s also in the portfolio – many of OFS’s loans are illiquid, and the large Pfanstiehl stake is highly illiquid. This means NAV may be slow to respond to market changes (until quarterly valuations) and the true liquidation value of assets could differ from marks.

In sum, OFS carries above-average risk for a BDC. The rewards (a 15% yield and possible capital appreciation) might compensate, but investors should go in with eyes open to these red flags. It is not a steady, sleep-well-at-night income stock; it’s a special situation that requires due diligence and risk tolerance.

Outlook and Open Questions

OFS Capital’s situation presents a mix of enticing opportunity and significant uncertainty. The title of this report – “Don’t miss today’s game-changing IPO opportunity!” – alludes to the optimistic scenario: that one of OFS’s private holdings (likely Pfanstiehl) could soon IPO or be sold, unlocking substantial value. Indeed, such an event would be transformative. If Pfanstiehl were to go public at a rich valuation, OFS could potentially realize tens of millions in gains, boosting NAV and possibly allowing a large special dividend or reinvestment into income-generating assets. This could vindicate the bulls and reward patient shareholders. It’s the kind of catalyst that could quickly close OFS’s price-to-book discount if it materializes. However, timing and execution are key – there’s no guarantee when or if this IPO/exit will occur, or at what valuation. This leads to several open questions:

– Will OFS actually capitalize on Pfanstiehl’s value? Thus far, OFS has only unrealized marks on this investment. An open question is whether and when management can convert it to cash. If an IPO comes, will OFS sell shares into the offering or shortly after? If a private sale comes, will OFS get liquidity or continue as a minority holder under new ownership? The strategy here will significantly affect OFS’s risk profile and liquidity. Until we see a monetization, Pfanstiehl’s value is theoretical. Investors should watch for news on this front in coming quarters – it’s the game-changer to either seize or slip by.

– Can OFS improve its earnings to cover the dividend? Absent one-time gains, OFS needs higher NII to maintain its payout long term. That likely means growing the loan portfolio (deploying available capital) and/or reducing funding costs. In 2024, OFS’s portfolio actually shrank somewhat, and management noted a lack of sufficient new investment activity to offset earnings declines (^[8]). Will OFS’s advisor ramp up originations in attractive deals to boost interest income? The company does have dry powder (credit facility capacity) to make new loans. The hurdle is doing so prudently, given a softer economic environment. Additionally, can OFS find ways to trim expenses or fees to help NII? As a small BDC, operating expenses and management fees take a big bite. It’s worth following management’s commentary on pipeline and portfolio growth – renewed portfolio expansion could signal confidence and improve income, whereas stagnation could presage a dividend cut or further NAV erosion.

– What is the trajectory of NAV from here? NAV per share was $12.85 at the end of 2024 (^[9]), then dropped to $10.91 by mid-2025 (^[3]) due to net losses on investments. Looking ahead, will NAV stabilize or continue trending down? This hinges on credit performance and the valuation of that big equity stake. Any improvement in credit (e.g., a troubled loan restored to accrual, or selling a non-accrual loan at better-than-mark) could boost NAV slightly. But the elephant in the room is Pfanstiehl – its valuation changes can swing NAV by dollars per share. A positive resolution (sale/IPO) could add to NAV (if it goes off above current carrying value), whereas an adverse development could cut NAV further. OFS’s NAV direction will likely remain lumpy and unpredictable quarter-to-quarter. Prospective investors should be comfortable with that volatility and consider whether they have an edge in assessing OFS’s asset value.

– How will interest rate changes impact OFS? The market expects the Federal Reserve to possibly cut rates in 2024–2025. As noted, rate cuts have started to reduce OFS’s asset yields (^[15]). If this continues, OFS’s NII could decline further, unless offset by higher leverage or wider spreads on new loans. Paradoxically, a lower-rate environment might also increase the value of OFS’s fixed-rate debt investments or make refinancing cheaper for OFS’s borrowers (reducing default risk). So there are pluses and minuses. The open question is whether OFS’s largely floating-rate portfolio will be a headwind or if management can adjust the portfolio mix (perhaps adding some fixed-rate assets or utilizing rate floors) to navigate a rate cut cycle. Furthermore, if the Fed’s easing stabilizes the economy, it could be good for credit quality, which benefits OFS. These dynamics are complex, and investors will need to monitor both OFS’s quarterly reports and macro indicators.

In conclusion, OFS Capital is a high-yield, high-risk play that might not be appropriate for all income investors – but it undeniably has intriguing potential. The stock’s deep discount and double-digit yield suggest that the market is pricing in a lot of bad news (and perhaps a dividend cut). If that pessimism proves overdone – for example, if a “game-changing” portfolio IPO hits pay dirt or if earnings coverage improves – there is considerable room for upside in the share price. At the same time, many of the concerns are valid: concentrated exposure, an uncovered dividend, and external management conflicts are not to be taken lightly.

Prospective investors should perform thorough due diligence and size any position in OFS according to their risk tolerance. Consider catalysts and timeline: is the potential Pfanstiehl liquidity event imminent or a long way off? One may not want to “miss” the opportunity, but one also doesn’t want to catch a falling knife if broader conditions worsen. For now, OFS Capital is best viewed as a special-situation stock. Keep an eye on those SEC filings and press releases for developments on the IPO/asset sale front (^[9]) (^[13]), and on management’s moves to address the earnings shortfall. The coming year or two should bring clarity to whether OFS turns its large unrealized gains into realized value – or whether income investors end up disappointed.

Open Question: Will the promise of OFS’s “game-changing” IPO catalyst pan out before the structural challenges (like the dividend strain or credit issues) catch up with the company? The answer to that will likely determine if today’s investors reap outsized rewards or not. As a senior equity analyst, my final take is that OFS offers a bold opportunity tempered by very real risks – a classic case of high risk, high potential reward. Investors shouldn’t miss doing their homework on this one. (^[8]) (^[13])

Sources

1. https://macrotrends.net/stocks/charts/OFS/ofs-capital/dividend-yield-history
2. https://finance.yahoo.com/quote/OFS/?fr=sycsrp_catchall%2F
3. https://ir.ofscapitalcorp.com/news-releases/news-release-details/ofs-capital-corporation-announces-second-quarter-2025-financial
4. https://ir.ofscapitalcorp.com/news-releases/news-release-details/ofs-capital-corporation-announces-second-quarter-2020-financial
5. https://ycharts.com/companies/OFS/dividend
6. https://ir.ofscapitalcorp.com/news-releases/news-release-details/ofs-capital-corporation-announces-third-quarter-2023-financial
7. https://ir.ofscapitalcorp.com/news-releases/news-release-details/ofs-capital-corporation-announces-third-quarter-2024-financial
8. https://seekingalpha.com/article/4791516-ofs-capital-the-dividend-needs-to-be-reduced
9. https://ir.ofscapitalcorp.com/news-releases/news-release-details/ofs-capital-corporation-announces-fourth-quarter-2024-financial
10. https://sec.gov/Archives/edgar/data/1487918/000148791823000011/ofs-20221231.htm
11. https://ir.ofscapitalcorp.com/news-releases/news-release-details/ofs-capital-corporation-announces-first-quarter-2024-financial
12. https://ir.ofscapitalcorp.com/news-releases/news-release-details/ofs-capital-corporation-announces-fourth-quarter-and-full-year-9
13. https://sec.gov/Archives/edgar/data/1487918/000148791824000076/ofs-20240630.htm
14. https://ir.ofscapitalcorp.com/news-releases/news-release-details/ofs-capital-corporation-announces-fourth-quarter-and-full-year-7
15. https://ir.ofscapitalcorp.com/news-releases/news-release-details/ofs-capital-corporation-announces-first-quarter-2025-financial

For informational purposes only; not investment advice.